Extractables and Leachables Testing

Extractables and Leachables Testing

Products & Services

Information

Our scientists conduct E&L analysis studies in accordance with regional guidance and nationally and internationally recognized standards, including Good Manufacturing Practice (GMP), Product Quality Research Institute (PQRI) extractables and leachables guidelines, United States Pharmacopeia (USP) requirements (e.g., USP chapters <665>, <1665>, <1663>, <1664>, and <1664.1>), Korean Pharmacopeia requirements, European Medicines Agency (EMA) guidance, US Food and Drug Administration (FDA) guidance, BioPhorum/BPOG guidance, and ISO 10993-18 extractables and leachables guidelines (Part 18). We also provide testing of glass packaging according to USP<1660> Glass Delamination Studies. As an initial step, we aim to gather all information about your packaging system in order to build a robust picture of potential sources of leachables. The combination of our experience in method development for a controlled extractables study, coupled with our vast knowledge of leachable compounds and guidelines, means that we can anticipate and identify potential sources of risk associated with leachable impurities through strategic screening studies. Our analytical teams can determine both organic and inorganic contaminants through the application of a range of advanced analytical instrumentation including liquid chromatography with HRAM-mass spectrometry detection (LC-MS/MS), gas chromatography with enhanced resolution or HRAM-mass spectrometry (GC-MS/MS), and inductively coupled plasma spectroscopy (ICP-OES or ICP-MS). In addition to the solvent-based extractions, we also apply various high performance automated solventless extraction methods, such as solid-phase microextraction (SPME), dynamic head-space and thermal desorption for better characterisation and understanding of materials. Typical study types include extractables assessment of container closure systems and packaging components. https://www.intertek.com/pharmaceutical/analysis/extractables-leachables/
Intertek213Intertek Pharmaceutical Services – Bringing Quality, Safety and Sustainability to Life. Our bespoke, purpose-built GLP / GCP / GMP laboratories have supported developers and manufacturers for over 30 years by providing bioanalytical studies and advanced characterisation programs. We have worked on multiple studies involving cell or gene therapies, mRNA, plasmid DNA based products, and other advanced modalities. Our facility has been designed to handle recombinant genomic materials for the purposes of research and compliant testing, including specialist facilities for handling Class I and Class II Biological Agents. Intertek’s innovative bio/pharmaceutical services are delivered consistently with precision, pace, and passion, enabling you, our customer, to power ahead safely. Our solutions: • Cell and virus characterisation • Virology assays • Host cell and residual plasmid DNA • Cell-based assays / potency testing • General compendial testing • GMP analysis • GCP/GLP bioanalysis • ICH stability storage and testing • Method development and validation • QC release testing • Advanced delivery technology analytical support Find out more: www.intertek.com/pharmaceutical/biopharmaceuticals/gene-therapy-characterisation Contact us today: +44 (0)116 296 1620 | pharma.services@intertek.com Follow us: www.linkedin.com/showcase/intertek-pharma  ATMP Analytical Development Services & CMC Support Presentation Request | AAV Therapies: Developing Effective Analytical Strategies for In-Depth Empty vs Full Capsid Characterization > Brochure | Cell and Gene Therapies Analytical Development Services >

Log in

See all the content and easy-to-use features by logging in or registering!